Decrease in plasma glucagon levels tended to be faster in the NAFLD compared to the NASH subgroup (Figure 3F), however the difference was not statistically significant (Table 3; Figure 3F). Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.